International Survey says Hungary is a Regional First in Biotech

San Francisco-based Burrill & Company’s, comprising biotech analysts and investment consultants, has published its latest annual report.

San Francisco-based Burrill & Company’s, comprising biotech analysts and investment consultants, has published its latest annual report (Biotech 2010—Life Sciences: Adapting for Success) on the global life sciences industry. In the report, it also explored the progress of the developing markets, listing Hungary alongside Latin America, China, South Korea, India and Malaysia.
For the first time, the American analyst firm has dedicated a section of its annual industry report to Hungary, which was shown to have outstanding growth potential in the company's in-depth international comparison of the sector.
 

News Monitoring